PHILADELPHIA — A systolic blood pressure treatment target under 120 mm Hg improved outcomes and saved lives compared with a threshold of 140 mm Hg for higher risk patients with hypertension, the ESPRIT trial from China affirmed. The more intensive target lowered 3-year incidence of the primary composite endpoint of myocardial infarction, revascularization, heart failure […]
Participant characteristics This study included 6800 patients with primary brain tumour diagnosed in Wales 2000–2014 and their 33,785 age-, sex- and GP practice-matched controls. Cohort selection is presented in Fig. 1. The total follow-up time for brain tumour patients and their controls were 32,453.9 person-year (median 3.5 years; interquartile range [IQR] 3.5–10.1) and 247,142.1 person-year (median 6.6 years; […]
Key Points Question Across US neighborhoods, is there an association between cumulative environmental burden and cardiovascular health? Findings In this cross-sectional study of 71 659 US Census tracts, neighborhoods in the top quartile of environmental burden experienced significantly higher rates of cardiovascular risk factors (hypertension, diabetes, and obesity) and diseases (coronary heart disease and stroke) compared […]
The earlier a woman gets her blood pressure controlled after giving birth, the quicker the blood pressure will return to normal levels and the healthier the heart will be, a new study found. The study—presented November 11, 2023, at the American Heart Association’s Scientific Sessions 2023 (AHA) in Philadelphia, Pennsylvania as a late breaker—examined postpartum […]
Research Highlights: In this first trial in people, a single dose of a new therapeutic called lepodisiran reduced the harmful risk factor lipoprotein(a), or Lp(a), by up to 94%, with reductions lasting nearly a year. Lepodisiran is a small interfering RNA that lowers Lp(a) by blocking the production in the liver of a key protein […]
Nov 12, 2023, 5:56pmUpdated 11h ago Doctors say one new development may lead to more insurance companies covering the costs of popular weight loss drugs. A recent study shows that the main ingredient in Wegovy, Semaglutide, can help reduce heart attacks, strokes and other cardiovascular issues by 20%. For three years, researchers tracked more than […]
There are close connections between obesity, diabetes, chronic kidney disease (CKD), and the cardiovascular system that can be understood through the cardiovascular-kidney-metabolic (CKM) construct, explained Chiadi Ndumele, MD, PhD, FAHA, the Robert E. Meyerhoff assistant professor at Johns Hopkins University, during a session at the American Heart Association (AHA) Scientific Sessions 2023 in Philadelphia, Pennsylvania. […]
An intensive program to lower blood pressure was associated with 15%decrease in dementia from all causes, according to results from presented Saturday at the American Heart Association Scientific Sessions meeting in Philadelphia. Although dementia is commonly viewed as consequences of neurological changes in the brain, it can also be caused by vascular disease. Sandra Taler, […]
CLEVELAND – Semaglutide, which is a popular drug used to treat diabetes, could soon have another use. Cleveland Clinic researchers found it may also be able to reduce the risk of cardiovascular events in individuals who are not diabetic. “The goal of this trial was to see whether in patients with overweight and obesity, who […]
Share on PinterestExperts say people with a family history of high cholesterol should get tested. Sergey Narevskih/Stocksy Researchers say genetic testing can help identify people with a family history known as familial hypercholesteremia. They say that identifying the condition can help medical professionals prescribe treatments and interventions. Experts recommend that people with this family history […]